Effects of Home-based Lower Extremity Muscle Power Training on Functional Muscle and Balance Performance in Older Adults

August 28, 2025 updated by: National Yang Ming Chiao Tung University

Background: Muscle power, defined as the rate at which muscular force is generated to produce movement, declines more rapidly with age than muscle strength. The decline in lower extremity muscle power is associated with reduced functional independence, impaired mobility, and an increased risk of falls among older adults. While power training has been shown to improve muscle power, balance, and functional abilities, the feasibility and effectiveness of home-based interventions have not been thoroughly investigated.

Purpose: The aim of this study is to investigate the effects of home-based lower extremity muscle power training program on functional muscle and balance performance in older adults.

Methods: This is a single-blind, randomized controlled trial. Forty community-dwelling older adults will be recruited and randomly assigned to the experimental group (n=20) and control group (n=20). Participants in the experimental group will complete 24 sessions of home-based lower extremity muscle power training targeting the lower limb muscle groups in 8 weeks. The training intensity will be progressively adjusted according to participants' performance. Participants in the control group will maintain their daily activities. In addition, both groups will receive health education. Primary outcomes include functional muscle power measured by the Four-Step Stair Climb Power Test, functional muscle strength measured by Five Times Sit-to-Stand Test, and the functional balance performance measured by the Mini-BESTest, and Timed Up and Go Test. The fall confidence, as the secondary outcome, will be measured by Falls Efficacy Scale International.

Statistical analysis: The SPSS® version 29 will be used for statistical analysis. Independent-t-test or chi-square test will be conducted to compare the baseline demographic characteristics between groups. Two-way repeated measure ANOVA will be used to compare the differences between groups and times, post-hoc analyses will be performed using Tukey's test. The significance level is set at 0.05.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Taipei, Taiwan, 112
        • Recruiting
        • National Yang Ming Chiao Tung University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 65~80 years old community-dwelling adults
  • MMSE≥24
  • Use smart phone routinely

Exclusion Criteria:

  • Recent (<1 year) musculoskeletal injury or disability in the lower limbs
  • Unstable cardiovascular, neurological disease, or metabolic disease interfering with participating in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Control group
Health education
Health education
Experimental: Experimental group
Total 40~60 minutes, 3 sessions per week in alternate day for 8 weeks, total 24 sessions
Total 40~60 minutes, 3 sessions per week in alternate day for 8 weeks, total 24 sessions 5 min warm up and 5 min cool down Power training (using body weight as resistance): hip flexor, hip extensor, hip adductor, hip abductor, knee flexor, ankle plantarflexor, hip external rotator, hip internal rotator, knee extensor, ankle dorsiflexor, ankle invertor, ankle evertor

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional muscle performance-muscle power
Time Frame: From baseline to the end of treatment at 8 weeks
The Four-Step Stair Climb Power Test is used for measurement, where participants rapidly ascend four steps while the required time is recorded. This test is designed to assess lower limb muscle power.
From baseline to the end of treatment at 8 weeks
Functional muscle performance-muscle strength
Time Frame: From baseline to the end of treatment at 8 weeks
The 5 Times Sit-to-Stand Test is used for measurement, where participants quickly and continuously perform five sit-to-stand movements while the required time is recorded. This test is designed to assess lower limb muscle strength.
From baseline to the end of treatment at 8 weeks
Balance
Time Frame: From baseline to the end of treatment at 8 weeks
The Mini-BESTest (Balance Evaluation Systems Test) is used for measurement. This test includes anticipatory control, reactive postural control, sensory orientation, and dynamic gait, allowing for the assessment of balance abilities related to postural control.
From baseline to the end of treatment at 8 weeks
Timed Up and Go Test
Time Frame: From baseline to the end of treatment at 8 weeks
The Timed Up and Go (TUG) Test is conducted at both a normal and fast pace to assess the balance and mobility of community-dwelling older adults in functional activities.
From baseline to the end of treatment at 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fall confidence
Time Frame: From baseline to the end of treatment at 8 weeks
The Falls Efficacy Scale International (FES-I) is used for assessment. This scale evaluates the level of confidence in not falling while performing activities of daily living.
From baseline to the end of treatment at 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ray-Yau Wang, PhD, National Yang Ming Chiao Tung University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 16, 2025

Primary Completion (Estimated)

April 30, 2026

Study Completion (Estimated)

April 30, 2026

Study Registration Dates

First Submitted

March 24, 2025

First Submitted That Met QC Criteria

March 24, 2025

First Posted (Actual)

March 30, 2025

Study Record Updates

Last Update Posted (Estimated)

September 5, 2025

Last Update Submitted That Met QC Criteria

August 28, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Older Adults

Clinical Trials on control group

Subscribe